GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tsumura & Co (TSE:4540) » Definitions » EBITDA Margin %

Tsumura (TSE:4540) EBITDA Margin % : 27.06% (As of Sep. 2024)


View and export this data going back to 1980. Start your Free Trial

What is Tsumura EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Tsumura's EBITDA for the three months ended in Sep. 2024 was 円12,281 Mil. Tsumura's Revenue for the three months ended in Sep. 2024 was 円45,381 Mil. Therefore, Tsumura's EBITDA margin for the quarter that ended in Sep. 2024 was 27.06%.


Tsumura EBITDA Margin % Historical Data

The historical data trend for Tsumura's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tsumura EBITDA Margin % Chart

Tsumura Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.91 25.22 26.96 24.20 23.08

Tsumura Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.50 32.17 10.72 42.89 27.06

Competitive Comparison of Tsumura's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Tsumura's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tsumura's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tsumura's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Tsumura's EBITDA Margin % falls into.



Tsumura EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Tsumura's EBITDA Margin % for the fiscal year that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=34820/150845
=23.08 %

Tsumura's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=12281/45381
=27.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tsumura  (TSE:4540) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Tsumura EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Tsumura's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tsumura Business Description

Traded in Other Exchanges
Address
2-17-11, Akasaka, Minato-ku, Tokyo, JPN, 107-8521
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Tsumura Headlines

No Headlines